Duration of Ameluz Application in Acral Actinic Keratoses Response
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
A phase IV study of a single topical application of ALA for 3 hours or 4 hours to AK on acral
sites (hands, feet, arms and legs), and subsequent measurement of clinical efficacy with
corresponding PpIX fluorescence imaging.